Welcome to our dedicated page for INDIVA news (Ticker: NDVAF), a resource for investors and traders seeking the latest updates and insights on INDIVA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect INDIVA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of INDIVA's position in the market.
Indiva Limited (NDVAF) reported a strong year-over-year revenue growth of 41.2% for Q1 2022, with gross revenues reaching $9.7 million. However, there was a sequential revenue decline of 6.6%. Net revenue also saw a 43.8% increase year-over-year to $8.95 million, while gross profit increased to 30% of net revenue compared to 19% in Q1 2021. The company remains the leading national market share holder in the edibles category, with a 34.2% share. Indiva launched its consumer brand, Indiva Life, aiming to introduce several new products in 2022.
Indiva Limited (TSXV: NDVA, OTCQX: NDVAF), a key Canadian cannabis producer, is set to release its financial results for Q1 2022 on May 19, 2022, before market opening. A conference call will follow at 8:30 a.m. (EST) for discussion of the results. Interested parties can join via phone at 416-764-8658 or 1-888-886-7786, using conference ID 53550245. The call's recording will be available for replay until June 19, 2022.
Indiva produces several award-winning cannabis products including Bhang® Chocolate and Wana™ Sour Gummies.
Indiva Limited (TSXV: NDVA; OTCQX: NDVAF) reported record financial results for Q4 and fiscal year 2021, with gross revenue of $10.39 million in Q4, a 25.1% increase sequentially, and $35.43 million for the year, up 118.9% year-over-year. Net revenue reached $9.45 million in Q4, with edible products accounting for 87% of sales. Despite a net loss of $4.13 million in Q4, improved gross margins and market dominance in the edibles sector were highlighted. New licensing agreements and product innovations are expected to drive future growth and profitability.
Indiva Limited (TSXV: NDVA) has announced a licensing and manufacturing agreement with California's Dime Industries to introduce its innovative vape products to Canada. This partnership will expand Indiva's product range beyond its popular edibles, marking its entry into the vape market. The agreement has an initial term of five years and includes automatic renewals for three additional five-year periods. Production of Dime vape products in Canada is expected to start soon, with deliveries to wholesalers targeted for Q3 2022.
On April 7, 2022, Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) announced it will report its annual results for the year ending December 31, 2021, on April 26, 2022, before the market opens. A conference call to discuss these results is scheduled for the same day at 8:30 AM EST. Participants can join by calling 416-764-8658 or 1-888-886-7786 with conference ID 17137881. The call's recording will be available for replay until May 26, 2022. Indiva is recognized for its high-quality cannabis products, including edibles, capsules, and premium flower.
Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) has appointed Ms. Rachel Goldman to its board of directors, bringing over 20 years of experience in finance and capital markets. The company also granted 2,130,000 stock options at $0.275 per share, expiring in 2026. Indiva renewed marketing service agreements with Simone Capital and Lock Consulting, with monthly retainers of CAD$5,000. Furthermore, Indiva will satisfy CAD$15,750 in interest payments through the issuance of shares to related parties and others, pending approval from the TSX Venture Exchange.
Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) has announced a Licensing and Manufacturing Agreement with Oregon-based Grön to launch a new edibles brand portfolio in Canada. This five-year agreement aims to enhance Indiva's product lineup by introducing unique minor cannabinoid ratios and innovative products following the company's previous successes in the cannabis edibles market. Production of Grön products is anticipated to commence by late Q2 2022, marking a significant expansion opportunity for Indiva in the growing Canadian cannabis sector.
Indiva Limited (NDVAF) reported strong Q3 2021 results, with gross revenue of $8.3 million, up 143% year-over-year, despite a sequential decline of 15.9%. Net revenue increased by 155% to $7.72 million. The period marked the 7th consecutive quarter of year-over-year net revenue growth. Adjusted EBITDA was positive at $0.17 million, down sequentially from Q2. Indiva maintains a leading market share in Canada's edibles category at 45%. The company expects continued revenue growth and margin improvement into Q4 2021 and 2022, supported by new product introductions.
Indiva Limited (TSXV: NDVA, OTCQX: NDVAF), a top Canadian producer of cannabis edibles, will disclose its financial results for the three and nine months ended September 30, 2021, on November 16, 2021, before market opening. A conference call is scheduled for 8:30 am EST on the same day. Additionally, an investor presentation hosted by CEO Niel Marotta will occur on December 2, 2021, at 4:00 pm EST. For more details, visit Indiva's website.
Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) reported record financial results for Q2 2021, with gross revenue reaching $9.87 million, a 249% year-over-year increase. Net revenue also hit a record $9.08 million, up 255% from Q2 2020. The company achieved a gross profit of $3.08 million, equating to a 34% gross margin. Indiva's positive adjusted EBITDA was $0.54 million, a significant turnaround from losses in previous periods. The company anticipates continued growth in the second half of 2021, driven by new product introductions and lower distillate costs.
FAQ
What is the current stock price of INDIVA (NDVAF)?
What is the market cap of INDIVA (NDVAF)?
